Global Penny Stocks With Market Caps Larger Than US$60MSimplywall·Jun 11 at 04:20 AM002004+0.68%00979-6.56%
HUAPONT LIFE SCIENCES: The company has not yet engaged in the brain-computer interface businessZhitong·Oct 29, 2025 at 10:45 PM002004+0.68%
Innovative drug concept stocks continue to be active, HUAPONT LIFE SCIENCES hits the limit upZhitong·Oct 16, 2025 at 08:44 PM300683+7.29%002004+0.68%
HUAPONT LIFE SCIENCES' subsidiary has obtained the drug registration certificate for Mometasone Furoate CreamZhitong·Sep 16, 2025 at 04:24 AM002004+0.68%
HUAPONT LIFE SCIENCES: Net profit of 388 million yuan in the first half of 2025, a year-on-year increase of 23.90%Zhitong·Aug 19, 2025 at 03:40 AM002004+0.68%
Shareholder of KS New Materials, HUAPONT LIFE SCIENCES, plans to inquire about the transfer of 4.75% of the company's sharesZhitong·Jul 16, 2025 at 08:16 AM301069+2.04%002004+0.68%
HUAPONT LIFE SCIENCES: Fusidic Acid Cream and Fluticasone Propionate Cream have obtained drug registration certificatesZhitong·Jun 23, 2025 at 10:48 PM002004+0.68%
HUAPONT LIFE SCIENCES: Elected Zhang Songshan as ChairmanZhitong·May 14, 2025 at 06:28 AM002004+0.68%
HUAPONT LIFE SCIENCES released its first-quarter performance, with a net profit attributable to the parent company of 184 million yuan, a year-on-year increase of 18.50%Zhitong·Apr 22, 2025 at 10:14 AM002004+0.68%
HUAPONT LIFE SCIENCES released its 2024 annual performance, turning from profit to a loss of 299 million yuanZhitong·Apr 22, 2025 at 10:14 AM002004+0.68%
HUAPONT LIFE SCIENCES subsidiary obtains drug registration certificate for Calcipotriol and Betamethasone OintmentZhitong·Mar 27, 2025 at 04:11 AM002004+0.68%
HUAPONT LIFE SCIENCES: The non-public issuance of exchangeable corporate bonds has received a no-objection letter from the Shenzhen Stock ExchangeZhitong·Mar 20, 2025 at 10:57 PM002004+0.68%
HUAPONT LIFE SCIENCES: Plans to use idle self-owned funds for financial management, with an amount not exceeding 2.3 billion yuanZhitong·Mar 6, 2025 at 06:58 AM002004+0.68%
HUAPONT LIFE SCIENCES hit the limit down, reaching a new low in over 4 months, with an annual expected loss exceeding 217 million yuanZhitong·Jan 19, 2025 at 11:46 PM002004+0.68%
HUAPONT LIFE SCIENCES: Expected net profit loss of 310 million to 217 million yuan in 2024Zhitong·Jan 17, 2025 at 05:35 AM002004+0.68%
